Carboxymethylcellulose Based Eye Drop Formulation A

DRUG2 trials

Sponsors

Allergan

Conditions

Dry Eye DiseaseDry Eye Syndromes

Phase 3

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

CompletedNCT01459588

AllerganDry Eye Syndromes

Start: 2011-10-01End: 2012-02-15Updated: 2019-04-16

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

CompletedNCT01664949

AllerganDry Eye Disease

Start: 2013-01-31End: 2014-05-31Updated: 2015-09-21